Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Oral administration of an herbal medicine to prevent progressive hearing loss in a mouse model of diabetes.

Hori T, Sugahara K, Tsuda J, Hirose Y, Hashimoto M, Takemoto Y, Tarumoto S, Yamashita H.

Auris Nasus Larynx. 2019 Oct;46(5):703-708. doi: 10.1016/j.anl.2019.01.011. Epub 2019 Feb 22.

PMID:
30799140
2.

Identification of baicalin from Bofutsushosan and Daisaikoto as a potent inducer of glucose uptake and modulator of insulin signaling-associated pathways.

Kuo YT, Lin CC, Kuo HT, Hung JH, Liu CH, Jassey A, Yen MH, Wu SJ, Lin LT.

J Food Drug Anal. 2019 Jan;27(1):240-248. doi: 10.1016/j.jfda.2018.07.002. Epub 2018 Aug 14.

3.

Comprehensive evaluation of antioxidant effects of Japanese Kampo medicines led to identification of Tsudosan formulation as a potent antioxidant agent.

Sato N, Li W, Takemoto H, Takeuchi M, Nakamura A, Tokura E, Akahane C, Ueno K, Komatsu K, Kuriyama N, Onoda T, Higai K, Koike K.

J Nat Med. 2019 Jan;73(1):163-172. doi: 10.1007/s11418-018-1259-x. Epub 2018 Oct 29.

PMID:
30374696
4.

Daisaikoto Inhibits Pancreatic Lipase Activity and Decreases Serum Triglyceride Levels in Mice.

Matsuo Y, Matsumoto K, Inaba N, Mimaki Y.

Biol Pharm Bull. 2018;41(9):1485-1488. doi: 10.1248/bpb.b18-00324.

5.

Effect of Daisaikoto on Expressions of SIRT1 and NF-kappaB of Diabetic Fatty Liver Rats Induced by High-Fat Diet and Streptozotocin.

Qian W, Cai X, Zhang X, Wang Y, Qian Q, Hasegawa J.

Yonago Acta Med. 2016 Jun 29;59(2):149-58. eCollection 2016 Jun.

6.

Analysis and Management of Rectal Gas with Kampo Formulas During Intensity-Modulated Radiotherapy of Prostate Cancer: A Case Series Study.

Nagai A, Shibamoto Y, Ogawa K, Inoda K, Yoshida M, Kikuchi Y.

J Altern Complement Med. 2016 Jun;22(6):480-5. doi: 10.1089/acm.2015.0271. Epub 2016 Apr 25.

PMID:
27110721
7.

Daisaikoto for menstrual pain: a lesson from a case with menstrual pain successfully treated with daisaikoto.

Horiba Y, Yoshino T, Watanabe K.

Case Rep Med. 2015;2015:929514. doi: 10.1155/2015/929514. Epub 2015 Feb 22.

8.

Da-Chaihu-Tang alters the pharmacokinetics of nifedipine in rats and a treatment regimen to avoid this.

He JX, Ohno K, Tang J, Hattori M, Tani T, Akao T.

J Pharm Pharmacol. 2014 Nov;66(11):1623-30. doi: 10.1111/jphp.12285. Epub 2014 Jun 24.

PMID:
24961584
9.

Traditional Chinese Medicine Induced Liver Injury.

Teschke R.

J Clin Transl Hepatol. 2014 Jun;2(2):80-94. doi: 10.14218/JCTH.2014.00003. Epub 2014 Jun 15. Review.

10.
11.
12.

Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use.

Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T.

Hum Exp Toxicol. 2006 Aug;25(8):481-94. Review.

PMID:
16937920
13.
14.
15.

Inhibitory effects of Dai-saiko-to (Da-Chai-Hu-Tang) on the progression of atherosclerotic lesions in Kurosawa and Kusanagi-hypercholesterolemic rabbits.

Iizuka A, Iijima OT, Yoshie F, Makino B, Amagaya S, Komatsu Y, Kondo K, Matsumoto A, Itakura H.

J Ethnopharmacol. 1998 Dec;63(3):209-18. Erratum in: J Ethnopharmacol 1999 Apr;65(1):79.

PMID:
10030725
16.
17.

[A case of drug induced hepatitis and interstitial pneumonia caused by a herbal drug, Dai-saiko-to].

Matsuda R, Takahashi D, Chiba E, Kawana I, Tomiyama M, Ebira H, Ikegami T, Kitamura H, Ishii M.

Nihon Shokakibyo Gakkai Zasshi. 1997 Nov;94(11):787-91. Japanese. No abstract available.

PMID:
9396337
18.
19.

Autoimmune hepatitis triggered by administration of an herbal medicine.

Kamiyama T, Nouchi T, Kojima S, Murata N, Ikeda T, Sato C.

Am J Gastroenterol. 1997 Apr;92(4):703-4. Review.

PMID:
9128330
20.

The inhibitory effects of dai-chai-hu-tang (dai-saiko-to) extract on supersaturated bile formation in cholesterol gallstone disease.

Shoda J, Matsuzaki Y, Tanaka N, Miyamoto J, Osuga T.

Am J Gastroenterol. 1996 Apr;91(4):828-30. No abstract available.

PMID:
8677979

Supplemental Content

Loading ...
Support Center